Head-To-Head Survey: Nutex Health (NUTX) vs. Its Competitors

Nutex Health (NASDAQ:NUTX – Get Rating) is one of 186 public companies in the “Business services, not elsewhere classified” industry, but how does it contrast to its rivals? We will compare Nutex Health to similar businesses based on the strength of its institutional ownership, analyst recommendations, earnings, profitability, dividends, risk and valuation.

Institutional and Insider Ownership

1.2% of Nutex Health shares are held by institutional investors. Comparatively, 53.1% of shares of all “Business services, not elsewhere classified” companies are held by institutional investors. 44.8% of Nutex Health shares are held by company insiders. Comparatively, 15.5% of shares of all “Business services, not elsewhere classified” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Nutex Health and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0	0	2	0	3.00
Nutex Health Competitors	765	4710	10039	252	2.62

Nutex Health presently has a consensus price target of $3.00, indicating a potential upside of 181.69%. As a group, “Business services, not elsewhere classified” companies have a potential upside of 22.04%. Given Nutex Health’s stronger consensus rating and higher probable upside, analysts clearly believe Nutex Health is more favorable than its rivals.

Profitability

This table compares Nutex Health and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nutex Health	-323.43%	-27.74%	-13.59%
Nutex Health Competitors	-45.43%	-9,147.49%	-5.15%

Risk & Volatility

Nutex Health has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Comparatively, Nutex Health’s rivals have a beta of 0.97, suggesting that their average share price is 3% less volatile than the S&P 500.

Valuation & Earnings

This table compares Nutex Health and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nutex Health	$219.29 million	-$424.78 million	-1.01
Nutex Health Competitors	$4.08 billion	$39.13 million	-16.63

Nutex Health’s rivals have higher revenue and earnings than Nutex Health. Nutex Health is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Summary

Nutex Health rivals beat Nutex Health on 7 of the 13 factors compared.

Nutex Health Company Profile

(Get Rating)

Nutex Health, Inc. operates as technology-enabled healthcare services. It has two divisions: a Hospital Division and a Population Health Management Division. The company was founded in 2011 and is headquartered in Houston, TX.